Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|6|2|110-117

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.6, Iss.2, 2011-05, pp. : 110-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem Cells in MDR-TB and XDR - TB

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 4, 2014-12 ,pp. : 238-240

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cells in MDR-TB and XDR - TB

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 4, 2015-05 ,pp. : 238-240

Bentham Science Publishers

Access to resources Recommend Favorite

Resistant TB: Newer Drugs and Community Approach

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 27-37

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Study of New TB Drugs and Drug Combinations in Mouse Models

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 102-116

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Compounds and Drugs and Recent Patents in Treating Multidrug- Resistant and Extensively Drug-Resistant Tuberculosis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 141-156

Bentham Science Publishers

Access to resources Recommend Favorite